Vertex Pharmaceuticals Incorporated
VRTX
$394.28
$0.800.20%
Headlines
4/20/2024
-
Fool.com Headlines
4/20/2024
-
Fool.com Headlines
4/19/2024
-
Zacks Investment Research
4/19/2024
-
Zacks Investment Research
4/19/2024
-
Fool.com Headlines
4/19/2024
-
Ticker Report
4/19/2024
-
Zolmax
4/18/2024
-
TipRanks Financial Blog
4/18/2024
-
Ticker Report
4/18/2024
-
TipRanks Financial Blog
Rakuten Securities Inc. Takes $173,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/18/2024
-
Ticker Report
4/18/2024
-
Zolmax
4/18/2024
-
Ticker Report
4/18/2024
-
The Fly
4/18/2024
-
Fool.com Headlines
4/18/2024
-
Business Wire
4/17/2024
-
Ticker Report
4/17/2024
-
Ticker Report
4/17/2024
-
Zolmax
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Ticker Report
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Ticker Report
4/15/2024
-
Ticker Report
Filings
Thursday, February 15, 2024
Sunday, December 31, 2023
Beginning of May (est)
Price History
Business Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF...
more